Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Molecular and Chemical Neuropathology|May 1, 1995
HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in ratsL Belayev, A Bar-Joseph, J Adamchik, et al.Life Sciences|April 25, 1983
Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormonesA Biegon, A Reches, L Snyder, et al.Brain Research|June 11, 1990
Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortemR Gross-Isseroff, D Salama, M Israeli, et al.Brain Research|January 22, 1990
Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicideR Gross-Isseroff, D Salama, M Israeli, et al.Journal of Neuroimmunology|January 8, 2000
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosisA Achiron, S Miron, V Lavie, et al.Brain Research|October 22, 1990
Regionally selective increases in mu opioid receptor density in the brains of suicide victimsR Gross-Isseroff, K A Dillon, M Israeli, et al.Journal of Physiology, Paris|January 1, 1994
The Maudsley rat strains as a probe to investigate noradrenergic-cholinergic interaction in cognitive functionS J Sara, V Devauges, A Biegon, et al.Life Sciences|November 14, 1983
Characterization of serotonin binding sites on human plateletsP A McBride, J J Mann, B McEwen, et al.Brain Research|July 19, 1991
Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcoholK A Dillon, R Gross-Isseroff, M Israeli, et al.European Journal of Pharmacology|September 5, 1995
Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonistN Eshhar, S Striem, R Kohen, et al.Pageof 10